,0.09230769230769231
%,0.7692307692307693
-0.07,0.015384615384615385
-0.08,0.015384615384615385
-0.18,0.015384615384615385
-0.30,0.015384615384615385
-10,0.015384615384615385
-1131T,0.015384615384615385
-1131T/C,0.046153846153846156
-26,0.015384615384615385
-493T,0.015384615384615385
-5,0.015384615384615385
-514T,0.015384615384615385
-6,0.015384615384615385
-70,0.015384615384615385
-8,0.046153846153846156
-9,0.015384615384615385
0.05-0.10,0.015384615384615385
0.23-1.00,0.015384615384615385
0.39-0.98,0.015384615384615385
1.7,0.015384615384615385
2,0.015384615384615385
4,0.015384615384615385
6.6,0.015384615384615385
<,0.27692307692307694
=,0.4153846153846154
>,0.06153846153846154
A,0.015384615384615385
A-V,0.015384615384615385
AA,0.03076923076923077
AA/AG,0.03076923076923077
ABCA1,0.09230769230769231
ACTCCG,0.015384615384615385
AD,0.1076923076923077
ADD1,0.03076923076923077
ADIPOR2,0.015384615384615385
AG/GG,0.015384615384615385
ALDH2,0.03076923076923077
AMD,0.18461538461538463
ANGPTL3,0.03076923076923077
ANOVA,0.015384615384615385
APOA5,0.3384615384615385
APOA5-S19W,0.015384615384615385
APOB,0.06153846153846154
APOC3,0.015384615384615385
APOE,0.18461538461538463
APOE-epsilon4,0.015384615384615385
ARMS2,0.015384615384615385
AUC,0.015384615384615385
Adults,0.015384615384615385
Africa,0.015384615384615385
African,0.015384615384615385
Alzheimer,0.015384615384615385
Americans,0.23076923076923078
Architecture,0.015384615384615385
Artery,0.015384615384615385
Asn291Ser,0.06153846153846154
Associations,0.015384615384615385
B1/B2,0.015384615384615385
B1B1,0.015384615384615385
B2,0.015384615384615385
BMI,0.12307692307692308
BP,0.046153846153846156
Body,0.015384615384615385
Bonferroni,0.015384615384615385
Busselton,0.015384615384615385
C,0.12307692307692308
C/T,0.015384615384615385
C/X,0.015384615384615385
C679X,0.015384615384615385
CASPIAN-III,0.015384615384615385
CC,0.1076923076923077
CD4,0.09230769230769231
CD8,0.046153846153846156
CD8-T,0.015384615384615385
CETP,0.35384615384615387
CFH,0.015384615384615385
CG,0.03076923076923077
CG+GG,0.015384615384615385
CHD,0.2153846153846154
CI,0.26153846153846155
CI=0.36-1.55,0.015384615384615385
CI=0.40-3.62,0.015384615384615385
CI=0.41-1.69,0.015384615384615385
CI=0.48-1.81,0.015384615384615385
CI=0.63-1.97,0.015384615384615385
CI=0.66-0.98,0.015384615384615385
CI=0.71-1.68,0.015384615384615385
CI=1.05-5.25,0.015384615384615385
CI=1.17-1.78,0.015384615384615385
CT+TT,0.015384615384615385
CVD,0.03076923076923077
CYP7A1,0.015384615384615385
Carriers,0.046153846153846156
China,0.03076923076923077
Common,0.03076923076923077
Complications,0.015384615384615385
Consequently,0.015384615384615385
Coronary,0.015384615384615385
D9N,0.12307692307692308
DPT,0.015384615384615385
DXA,0.015384615384615385
Development,0.015384615384615385
Disorder,0.015384615384615385
Doetinchem,0.015384615384615385
Dyslipidaemia,0.015384615384615385
ESR1,0.07692307692307693
Eastern,0.015384615384615385
Epidemiology,0.015384615384615385
Epistasis,0.015384615384615385
FA,0.015384615384615385
FABP2,0.06153846153846154
FAs,0.046153846153846156
FCHL,0.09230769230769231
FDR,0.015384615384615385
FDR_q,0.06153846153846154
Functional,0.015384615384615385
Furthermore,0.015384615384615385
G,0.046153846153846156
G188E,0.03076923076923077
GA,0.015384615384615385
GALNT2,0.015384615384615385
GALNTN2,0.015384615384615385
GCK,0.03076923076923077
GCKR,0.09230769230769231
GEnomics,0.015384615384615385
GG,0.09230769230769231
GWA,0.046153846153846156
GWAS,0.03076923076923077
Genome-wide,0.015384615384615385
Genomics,0.015384615384615385
HAART,0.015384615384615385
HDL,0.13846153846153847
HDL-C,0.5384615384615384
HDL-C.,0.015384615384615385
HDL-cholesterol,0.046153846153846156
HDLc,0.1076923076923077
HEK-293T,0.015384615384615385
HELENA,0.015384615384615385
HIV,0.015384615384615385
HIV+,0.015384615384615385
HL,0.046153846153846156
HMGCR,0.015384615384615385
HNF4A,0.03076923076923077
HR,0.03076923076923077
HT,0.09230769230769231
HTG,0.12307692307692308
Hap1,0.03076923076923077
Hap4,0.09230769230769231
Health,0.015384615384615385
HindIII,0.16923076923076924
Hypertension,0.015384615384615385
Hypertriglyceridemia,0.015384615384615385
Hypothyroidism,0.015384615384615385
IAUC,0.015384615384615385
IC95,0.03076923076923077
ICARIA,0.015384615384615385
ICD-9,0.07692307692307693
IG,0.015384615384615385
IG=2.24,0.015384615384615385
IG=6.20,0.015384615384615385
IL6,0.015384615384615385
Index,0.015384615384615385
Interactions,0.015384615384615385
Iran,0.015384615384615385
Istanbul,0.015384615384615385
January,0.015384615384615385
Just,0.015384615384615385
KCNH2,0.015384615384615385
KCTD10/MVK,0.015384615384615385
LDL,0.07692307692307693
LDL+HDL,0.046153846153846156
LDL-C,0.07692307692307693
LDLR,0.046153846153846156
LIPC,0.1076923076923077
LIPGENE,0.03076923076923077
LIPGENE-SU.VI.MAX,0.015384615384615385
LPL,1.0615384615384615
LPL-HindIII,0.03076923076923077
LPL-S477,0.015384615384615385
LPL-X447,0.015384615384615385
LRP5,0.015384615384615385
LV,0.046153846153846156
LVH,0.07692307692307693
LXR,0.015384615384615385
Lipid,0.015384615384615385
Lipoid,0.015384615384615385
Lipoprotein,0.046153846153846156
Longitudinal,0.046153846153846156
MBTPS2,0.03076923076923077
MEdical,0.015384615384615385
MLXIPL,0.015384615384615385
MTP,0.015384615384615385
MTTP,0.03076923076923077
MetS,0.16923076923076924
Meta-analyses,0.015384615384615385
Mexican,0.03076923076923077
MicroRNAs,0.015384615384615385
N291S,0.06153846153846154
NEFA,0.015384615384615385
NR1H3,0.07692307692307693
NRIP1,0.03076923076923077
Network,0.015384615384615385
Networks,0.015384615384615385
OR,0.16923076923076924
OR=0.75,0.015384615384615385
OR=0.80,0.015384615384615385
OR=0.83,0.015384615384615385
OR=0.93,0.015384615384615385
OR=1.09,0.015384615384615385
OR=1.11,0.015384615384615385
OR=1.21,0.015384615384615385
OR=1.44,0.015384615384615385
OR=2.34,0.015384615384615385
Obesity,0.015384615384615385
P,0.4307692307692308
P-values,0.015384615384615385
P=0.0006,0.015384615384615385
P=0.006,0.015384615384615385
P=0.007,0.015384615384615385
P=0.01,0.015384615384615385
P=0.02,0.015384615384615385
P=0.03,0.015384615384615385
P=0.034,0.015384615384615385
P=0.04,0.015384615384615385
P=0.05,0.015384615384615385
P=0.436,0.015384615384615385
P=0.604,0.015384615384615385
P=0.698,0.015384615384615385
P=0.712,0.015384615384615385
P=0.734,0.015384615384615385
P=0.841,0.015384615384615385
P=3.0510,0.015384615384615385
P=6.3610,0.015384615384615385
PAGE,0.015384615384615385
PCR,0.046153846153846156
PCR-AIRS,0.015384615384615385
PCR-RFLP,0.015384615384615385
PCR/PCR-RFLP,0.015384615384615385
PCSK9,0.046153846153846156
PLTP,0.015384615384615385
PPAR2,0.015384615384615385
PTPN11,0.03076923076923077
PUFA,0.03076923076923077
Pairwise,0.015384615384615385
Participants,0.046153846153846156
Patients,0.015384615384615385
Peroxisome,0.015384615384615385
PheWAS,0.046153846153846156
Pinteraction,0.03076923076923077
Plasma,0.03076923076923077
Population,0.015384615384615385
Populations,0.015384615384615385
PvuII,0.06153846153846154
RLPc,0.015384615384615385
Recent,0.015384615384615385
Records,0.015384615384615385
Risk,0.015384615384615385
Rs328,0.015384615384615385
Rs671,0.015384615384615385
S/S,0.03076923076923077
S/X,0.03076923076923077
S/X+X/X,0.015384615384615385
S19W,0.06153846153846154
S447,0.046153846153846156
S447X,0.18461538461538463
SA,0.07692307692307693
SC4MOL,0.03076923076923077
SCAND1,0.03076923076923077
SHBG,0.015384615384615385
SS,0.015384615384615385
SU.VI.MAX,0.015384615384615385
SUVIMAX,0.015384615384615385
SX,0.015384615384615385
Ser447Stop,0.015384615384615385
Ser447Ter,0.06153846153846154
Seven,0.015384615384615385
Shanghai,0.03076923076923077
Singaporeans,0.015384615384615385
South,0.015384615384615385
Statistical,0.015384615384615385
Substudy,0.015384615384615385
Survey,0.015384615384615385
T,0.015384615384615385
T-93G,0.03076923076923077
T-cell,0.07692307692307693
TAG,0.09230769230769231
TAG-AUC,0.015384615384615385
TAG-IAUC,0.015384615384615385
TBL2/MLXIPL,0.03076923076923077
TC,0.03076923076923077
TG,0.7538461538461538
TG-0.18,0.015384615384615385
TG-lowering,0.03076923076923077
TG-raising,0.015384615384615385
TRIB1,0.06153846153846154
TRL-TG,0.015384615384615385
TT,0.015384615384615385
TaqMan,0.015384615384615385
Triglyceride,0.015384615384615385
Triglycerides,0.015384615384615385
Turkey,0.015384615384615385
U.K.,0.015384615384615385
UCP3,0.015384615384615385
VLDLR,0.015384615384615385
ViSEN,0.03076923076923077
Visualization,0.015384615384615385
X447,0.046153846153846156
X447+,0.015384615384615385
Xhosa,0.015384615384615385
Young,0.015384615384615385
[,0.13846153846153847
],0.2
absence,0.03076923076923077
accumulation,0.015384615384615385
acid,0.03076923076923077
acids,0.06153846153846154
addition,0.046153846153846156
adjustment,0.03076923076923077
adolescence,0.015384615384615385
adolescents,0.12307692307692308
adulthood,0.03076923076923077
age,0.1076923076923077
aim,0.06153846153846154
aims,0.015384615384615385
alcohol,0.07692307692307693
alter,0.015384615384615385
alteration,0.015384615384615385
ancestry,0.06153846153846154
approach,0.03076923076923077
area,0.03076923076923077
artery,0.03076923076923077
assays,0.015384615384615385
assessment,0.015384615384615385
association,0.6
associations,0.4461538461538462
atherosclerosis,0.015384615384615385
authors,0.015384615384615385
basis,0.015384615384615385
binding,0.015384615384615385
binding-site,0.015384615384615385
binding-sites,0.03076923076923077
birth,0.046153846153846156
blood,0.1076923076923077
body,0.06153846153846154
boys,0.015384615384615385
c.1959T,0.015384615384615385
candidate,0.06153846153846154
candidates,0.015384615384615385
cardiovascular,0.015384615384615385
cardiovascular-diseases,0.015384615384615385
carotid,0.03076923076923077
carriers,0.13846153846153847
case,0.015384615384615385
case-control,0.03076923076923077
cases,0.046153846153846156
category,0.03076923076923077
cell,0.015384615384615385
cells,0.03076923076923077
chain,0.015384615384615385
challenge,0.03076923076923077
change,0.015384615384615385
changes,0.046153846153846156
children,0.06153846153846154
cholesterol,0.23076923076923078
cholesteryl,0.03076923076923077
cholesteryl-ester-transfer-protein,0.015384615384615385
chylomicrons,0.015384615384615385
circulating,0.015384615384615385
circumference,0.015384615384615385
code,0.046153846153846156
codes,0.015384615384615385
cohort,0.1076923076923077
combination,0.03076923076923077
combinations,0.06153846153846154
comparison,0.015384615384615385
comparisons,0.015384615384615385
components,0.046153846153846156
composition,0.03076923076923077
concentration,0.13846153846153847
concentrations,0.27692307692307694
conclusion,0.09230769230769231
confidence,0.03076923076923077
consequence,0.015384615384615385
constructs,0.015384615384615385
consumption,0.046153846153846156
contribute,0.015384615384615385
contribution,0.015384615384615385
contributions,0.03076923076923077
control,0.015384615384615385
controls,0.1076923076923077
convertase,0.015384615384615385
correction,0.015384615384615385
corrections,0.015384615384615385
count,0.046153846153846156
counts,0.015384615384615385
covariates,0.015384615384615385
criteria,0.015384615384615385
curve,0.03076923076923077
data,0.1076923076923077
dataset,0.015384615384615385
datasets,0.03076923076923077
dbSNP,0.015384615384615385
decay,0.015384615384615385
decrease,0.046153846153846156
dehydrogenase,0.015384615384615385
delivery,0.015384615384615385
density,0.07692307692307693
determinants,0.015384615384615385
determination,0.015384615384615385
development,0.06153846153846154
diabetes,0.015384615384615385
diagnoses,0.03076923076923077
diagnosis,0.015384615384615385
difference,0.015384615384615385
differences,0.06153846153846154
discovery,0.015384615384615385
disease,0.12307692307692308
diseases,0.015384615384615385
disequilibrium,0.015384615384615385
disorders,0.015384615384615385
distributions,0.015384615384615385
disturbances,0.015384615384615385
dominant,0.015384615384615385
down-regulation,0.015384615384615385
drink,0.015384615384615385
drinkers,0.03076923076923077
drinking,0.015384615384615385
dyslipidemia,0.12307692307692308
e.g.,0.015384615384615385
eMERGE,0.015384615384615385
effect,0.15384615384615385
effects,0.2
efforts,0.03076923076923077
energy,0.015384615384615385
enzyme,0.06153846153846154
ester,0.03076923076923077
events,0.015384615384615385
evidence,0.015384615384615385
examination,0.015384615384615385
examinations,0.015384615384615385
exception,0.015384615384615385
existence,0.015384615384615385
expression,0.015384615384615385
extremes,0.015384615384615385
factor,0.07692307692307693
factors,0.09230769230769231
family,0.015384615384615385
fasting,0.06153846153846154
features,0.03076923076923077
females,0.03076923076923077
findings,0.07692307692307693
fluvastatin,0.03076923076923077
follow-up,0.03076923076923077
fractions,0.015384615384615385
frequencies,0.015384615384615385
frequency,0.046153846153846156
function,0.015384615384615385
functionality,0.015384615384615385
gender,0.03076923076923077
genetic-polymorphisms,0.015384615384615385
genotyping,0.03076923076923077
girls,0.015384615384615385
glucokinase,0.015384615384615385
glucose,0.09230769230769231
glucose-AUC,0.015384615384615385
group,0.07692307692307693
groups,0.015384615384615385
growth,0.03076923076923077
haplotype,0.06153846153846154
heart,0.046153846153846156
height,0.015384615384615385
heterogeneity,0.015384615384615385
high-density,0.07692307692307693
high-resolution,0.015384615384615385
homeostasis,0.015384615384615385
homozygotes,0.03076923076923077
human,0.015384615384615385
hydrolysis,0.03076923076923077
hyperglyceridemia,0.015384615384615385
hyperlipidemia,0.015384615384615385
hypertension,0.03076923076923077
hypertensive,0.015384615384615385
hypertensives,0.03076923076923077
hypertriglyceridemia,0.046153846153846156
hypertriglyceridemias,0.16923076923076924
hypertrophy,0.015384615384615385
hypothesis,0.046153846153846156
i,0.015384615384615385
ii,0.015384615384615385
iii,0.015384615384615385
impact,0.046153846153846156
importance,0.015384615384615385
increase,0.13846153846153847
index,0.07692307692307693
individual,0.015384615384615385
individuals,0.16923076923076924
infarction,0.015384615384615385
infection,0.015384615384615385
influence,0.07692307692307693
influences,0.03076923076923077
information,0.03076923076923077
inheritance,0.015384615384615385
insights,0.015384615384615385
intake,0.03076923076923077
interact,0.015384615384615385
interaction,0.1076923076923077
interactions,0.06153846153846154
interacts,0.015384615384615385
interrelations,0.015384615384615385
interval,0.03076923076923077
investigation,0.015384615384615385
involvement,0.015384615384615385
irrespective,0.015384615384615385
isoforms,0.015384615384615385
knowledge,0.03076923076923077
level,0.13846153846153847
levels,0.6615384615384615
levels25th,0.015384615384615385
levels75th,0.015384615384615385
linkage,0.015384615384615385
lipaemia,0.015384615384615385
lipase,0.23076923076923078
lipid,0.03076923076923077
lipids,0.07692307692307693
lipometabolism,0.015384615384615385
lipoprotein,0.13846153846153847
list,0.015384615384615385
literature,0.03076923076923077
loci,0.03076923076923077
logTG-0.13,0.015384615384615385
loss,0.015384615384615385
magnitude,0.015384615384615385
majority,0.015384615384615385
males,0.03076923076923077
manner,0.03076923076923077
mass,0.06153846153846154
meal,0.03076923076923077
mean,0.015384615384615385
mechanism,0.03076923076923077
median,0.015384615384615385
medicine,0.015384615384615385
melt,0.015384615384615385
men,0.15384615384615385
meta-analyses,0.03076923076923077
meta-analysis,0.015384615384615385
metabolism,0.24615384615384617
method,0.015384615384615385
methods,0.015384615384615385
metoprolol,0.015384615384615385
miR,0.015384615384615385
miRNA,0.015384615384615385
mixed-effects,0.015384615384615385
mmol/L,0.03076923076923077
mmol/l,0.015384615384615385
mmol/liter,0.07692307692307693
model,0.046153846153846156
models,0.046153846153846156
mutation,0.015384615384615385
mutations,0.015384615384615385
n=148,0.015384615384615385
n=2716,0.015384615384615385
n=60,0.015384615384615385
need,0.015384615384615385
non-drinkers,0.015384615384615385
none,0.015384615384615385
nonsense,0.015384615384615385
normolipidemics,0.015384615384615385
novel,0.015384615384615385
number,0.03076923076923077
obese-subjects,0.015384615384615385
obesity,0.13846153846153847
odds,0.06153846153846154
order,0.015384615384615385
others,0.015384615384615385
p,0.12307692307692308
p.19W,0.03076923076923077
p.4181K,0.015384615384615385
p.474X,0.015384615384615385
p.55T,0.046153846153846156
p.E4181K,0.015384615384615385
p.Ser474Ter,0.03076923076923077
p=0.002,0.046153846153846156
p=0.005,0.015384615384615385
p=0.015,0.015384615384615385
p=0.018,0.015384615384615385
p=0.022,0.015384615384615385
p=0.024,0.015384615384615385
p=0.026,0.015384615384615385
p=0.037,0.015384615384615385
p=0.038,0.015384615384615385
p=0.046,0.015384615384615385
parameters,0.06153846153846154
part,0.015384615384615385
participant,0.015384615384615385
participants,0.09230769230769231
particle,0.015384615384615385
pathogenesis,0.015384615384615385
pathways,0.03076923076923077
patients,0.26153846153846155
percentile,0.015384615384615385
perspective,0.015384615384615385
phenotype,0.015384615384615385
phenotypes,0.09230769230769231
phenotypic,0.015384615384615385
photography,0.015384615384615385
plaque,0.03076923076923077
plasma,0.18461538461538463
platform,0.03076923076923077
pleiotropic,0.015384615384615385
pleiotropy,0.015384615384615385
polymerase,0.015384615384615385
population,0.07692307692307693
populations,0.1076923076923077
presence,0.07692307692307693
pressure,0.06153846153846154
prevalence,0.015384615384615385
procedures,0.015384615384615385
profile,0.1076923076923077
profiles,0.046153846153846156
progress,0.015384615384615385
progression,0.015384615384615385
proportion,0.015384615384615385
protein,0.046153846153846156
proteins,0.015384615384615385
quantity,0.015384615384615385
race,0.015384615384615385
race/ethnicity,0.015384615384615385
rate,0.015384615384615385
ratio,0.06153846153846154
ratios,0.015384615384615385
reaction,0.015384615384615385
receptor,0.015384615384615385
reduction,0.046153846153846156
regimen,0.015384615384615385
regression,0.06153846153846154
regulation,0.015384615384615385
relation,0.015384615384615385
relations,0.015384615384615385
relationship,0.015384615384615385
release,0.015384615384615385
remnant-like,0.015384615384615385
replicating,0.015384615384615385
replication,0.015384615384615385
reports,0.015384615384615385
respect,0.046153846153846156
response,0.03076923076923077
restriction,0.015384615384615385
result,0.015384615384615385
results,0.07692307692307693
risk,0.4
role,0.03076923076923077
rs1042031,0.015384615384615385
rs10490924,0.03076923076923077
rs1059611,0.03076923076923077
rs1061170,0.015384615384615385
rs11039155,0.015384615384615385
rs11066322,0.03076923076923077
rs1137617,0.015384615384615385
rs11591147,0.015384615384615385
rs12060879,0.015384615384615385
rs12130333,0.015384615384615385
rs12221497,0.015384615384615385
rs1260326,0.015384615384615385
rs12654264,0.015384615384615385
rs13702,0.03076923076923077
rs1529729,0.015384615384615385
rs17145738,0.03076923076923077
rs17231506,0.015384615384615385
rs17321515,0.015384615384615385
rs17585739,0.03076923076923077
rs1799883,0.015384615384615385
rs1799884,0.015384615384615385
rs1799941,0.015384615384615385
rs1800588,0.1076923076923077
rs1800590,0.015384615384615385
rs1800591,0.015384615384615385
rs1800775,0.03076923076923077
rs1800777,0.015384615384615385
rs1800795,0.015384615384615385
rs1800849,0.015384615384615385
rs1800961,0.03076923076923077
rs1800977,0.03076923076923077
rs1800978,0.015384615384615385
rs1801177,0.046153846153846156
rs1805192,0.015384615384615385
rs1884051,0.015384615384615385
rs2229741,0.03076923076923077
rs2338104,0.015384615384615385
rs2575879,0.015384615384615385
rs268,0.1076923076923077
rs2808607,0.015384615384615385
rs28362286,0.015384615384615385
rs285,0.046153846153846156
rs3135506,0.13846153846153847
rs320,0.12307692307692308
rs3208305,0.015384615384615385
rs3213451,0.03076923076923077
rs326,0.046153846153846156
rs328,0.5230769230769231
rs3812316,0.015384615384615385
rs3890182,0.015384615384615385
rs429358,0.015384615384615385
rs4420638,0.015384615384615385
rs4846914,0.015384615384615385
rs4961,0.03076923076923077
rs5882,0.03076923076923077
rs5925,0.015384615384615385
rs6060717,0.03076923076923077
rs6257,0.015384615384615385
rs651821,0.03076923076923077
rs662799,0.09230769230769231
rs671,0.03076923076923077
rs693,0.015384615384615385
rs6987702,0.015384615384615385
rs7007797,0.015384615384615385
rs708272,0.1076923076923077
rs7412,0.015384615384615385
rs780094,0.015384615384615385
sample,0.015384615384615385
samples,0.06153846153846154
schools,0.015384615384615385
score,0.1076923076923077
search,0.015384615384615385
sequence,0.015384615384615385
serum,0.15384615384615385
set,0.046153846153846156
sex,0.046153846153846156
significance,0.015384615384615385
signs,0.015384615384615385
site,0.03076923076923077
sites,0.046153846153846156
smoking,0.015384615384615385
stage,0.015384615384615385
stages,0.015384615384615385
standpoint,0.015384615384615385
state,0.03076923076923077
statin,0.015384615384615385
status,0.015384615384615385
stenosis,0.015384615384615385
step,0.015384615384615385
stop-gain,0.015384615384615385
structure,0.03076923076923077
students,0.015384615384615385
subgroup,0.015384615384615385
subgroups,0.015384615384615385
subjects,0.2
substrate,0.015384615384615385
subtilisin/kexin,0.015384615384615385
supplies,0.015384615384615385
surveillance,0.015384615384615385
survey,0.015384615384615385
susceptibility,0.015384615384615385
switches,0.015384615384615385
syndrome,0.03076923076923077
system,0.015384615384615385
systems,0.03076923076923077
target,0.046153846153846156
test,0.046153846153846156
testing,0.03076923076923077
tests,0.03076923076923077
therapy,0.046153846153846156
thrice,0.015384615384615385
time,0.07692307692307693
total,0.06153846153846154
trace,0.015384615384615385
trait,0.046153846153846156
traits,0.03076923076923077
transfer,0.03076923076923077
treatment,0.03076923076923077
trend,0.06153846153846154
triacylglycerol,0.09230769230769231
triglyceride,0.1076923076923077
triglycerides,0.3076923076923077
two-stage,0.015384615384615385
type,0.03076923076923077
understanding,0.015384615384615385
utilization,0.015384615384615385
validation,0.015384615384615385
value,0.015384615384615385
values,0.046153846153846156
variability,0.046153846153846156
variable,0.03076923076923077
variables,0.046153846153846156
variance,0.046153846153846156
variation,0.1076923076923077
variations,0.046153846153846156
ventricular,0.015384615384615385
waist-circumference,0.015384615384615385
warrants,0.015384615384615385
weight,0.1076923076923077
whereas,0.015384615384615385
wild-type,0.015384615384615385
women,0.2923076923076923
year,0.015384615384615385
years,0.1076923076923077
yields,0.015384615384615385
